Unknown

Dataset Information

0

Tumor control by human cytomegalovirus in a murine model of hepatocellular carcinoma.


ABSTRACT: Although viruses can cause cancer, other studies reported the regression of human tumors upon viral infections. We investigated the cytoreductive potential of human cytomegalovirus (HCMV) in a murine model of human hepatocellular carcinoma (HCC) in severe-immunodeficient mice. Infection of HepG2 cells with HCMV resulted in the absence of tumor or in a limited tumor growth following injection of cells subcutaneously. By contrast all mice injected with uninfected HepG2 cells and with HepG2 cells infected with UV-treated HCMV did develop tumors without any significant restriction. Analysis of tumors indicated that in mice injected with HCMV-infected-HepG2 cells, but not in controls, a restricted cellular proliferation was observed parallel to a limited activation of the STAT3-cyclin D1 axis, decreased formation of colonies in soft agar, and activation of the intrinsic apoptotic pathway. We conclude that HCMV can provide antitumoral effects in a murine model of HCC which requires replicative virus at some stages that results in limitation of tumor cell proliferation and enhanced apoptosis mediated through the intrinsic caspase pathway.

SUBMITTER: Kumar A 

PROVIDER: S-EPMC5008266 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tumor control by human cytomegalovirus in a murine model of hepatocellular carcinoma.

Kumar Amit A   Coquard Laurie L   Pasquereau Sébastien S   Russo Laetitia L   Valmary-Degano Séverine S   Borg Christophe C   Pothier Pierre P   Herbein Georges G  

Molecular therapy oncolytics 20160427


Although viruses can cause cancer, other studies reported the regression of human tumors upon viral infections. We investigated the cytoreductive potential of human cytomegalovirus (HCMV) in a murine model of human hepatocellular carcinoma (HCC) in severe-immunodeficient mice. Infection of HepG2 cells with HCMV resulted in the absence of tumor or in a limited tumor growth following injection of cells subcutaneously. By contrast all mice injected with uninfected HepG2 cells and with HepG2 cells i  ...[more]

Similar Datasets

| S-EPMC6982125 | biostudies-literature
| S-EPMC7481009 | biostudies-literature
| S-EPMC8321929 | biostudies-literature
| S-EPMC4450058 | biostudies-literature
| S-EPMC4607425 | biostudies-literature
| S-EPMC2928671 | biostudies-literature
| S-EPMC5522235 | biostudies-literature
| PRJEB62485 | ENA
| S-EPMC3243781 | biostudies-other
2022-03-14 | PXD025705 | Pride